Search results for: 'Biological antibody reagents US'

This Frost & Sullivan analysis examines the evolution of mobility innovation through a comprehensive benchmarking of automotive and mobility-related patents across connected, autonomous, shared, and electric (CASE) mobility dimensions. Using patent data from the United States Patent and Trademark Office spanning 1976 to 2040, the analysis maps lon...

07 Nov 2016  |  North America  |  Market Research

Market Analysis of Premium European OEMs' ADAS and Automated Driving (AD) Strategies

Along with Level 3 and 4 Functions, Shared Mobility Portfolio to Play a Key Role in OEMs’ Future Business Models

Infographics

×

While OEMs are racing towards achieving L4 and 5 automation features in their vehicles in developed markets such as NA and Europe, there will be major improvements in the ADAS sensors that will be used to achieve the desired features. Every OEM is working on a strategy that is different from others in terms of the level of automation desired. With ...

Autonomous driving and ADAS features are on the rise in the NA market. Market participants that offer vehicles with L1 and L2 capabilities dominate the current market. A few of these OEMs also have vehicles with L2+ capabilities. Vehicles with L2+ ADAS and L3 AD capabilities will dominate the future of the NA ADAS and AD markets. Because of the ple...